As the pot stock space continues to pick up steam in what appears to be a fresh bull cycle, it should be noted that Liberty Health Sciences Inc (OTCMKTS:LHSIF) just announced that it has entered into a licensing agreement with licensed California adult use and medicinal cannabis company HONEY, one of California’s largest full service companies, to supply all of Liberty’s dispensaries with the company’s full assortment of branded products.
According to the release, in 2012, HONEY revolutionized the cannabis industry by becoming the first producer in the world to market distilled cannabis oil in vape cartridges. Today, they provide authentic, full spectrum oil in vape cartridges, applicators, and caps to legal dispensaries and delivery services.
Liberty Health Sciences Inc (OTCMKTS:LHSIF) frames itself as a company that engages in the production and distribution of medical cannabis primarily in the State of Florida.
It has a strategic partnership with Veterans Cannabis Project to support various research projects focused on the treatment of service related trauma with cannabis derived products; and partnership with AdaViv Inc. to enhance production of cannabis.
The company is headquartered in Toronto, Canada.
Liberty Health Sciences was established to own and operate medical marijuana licenses in the United States. To date, the company owns one of 14 licenses issued in the state of Florida as well as 50.1% interest in a provisional processing license and a provisional dispensary license, both in Ohio. Liberty has also made an investment in a provisional medical license in the Commonwealth of Massachusetts.
According to company materials, “Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty’s measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers’ well-being at the forefront of what we do.”
Find out when $LHSIF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, LHSIF just announced that it has entered into a licensing agreement with licensed California adult use and medicinal cannabis company HONEY, one of California’s largest full service companies, to supply all of Liberty’s dispensaries with the company’s full assortment of branded products.
The chart shows 3% tacked on to share pricing for the listing in the past week. Furthermore, the listing has witnessed a pop in interest, as transaction volume levels have recently pushed 9% beyond what we have been seeing over the larger time frame.
“We are excited to partner with HONEY, a longstanding pioneer and premium brand in the cannabis space,” said Victor Mancebo, Chief Executive Officer of Liberty. “Adding HONEY to our portfolio of brands creates an immediate distinction between other competitors in the space and reinforces our product offering strategy to provide variety, quality, and price versatility in all of the products we market.”
At this time, carrying a capital value in the market of $131.5M, LHSIF has a significant war chest ($25M) of cash on the books, which compares with about $25.5M in total current liabilities. One should also note that debt has been growing over recent quarters. LHSIF is pulling in trailing 12-month revenues of $50.1M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 413.1%. You can bet we will update this one again as new information comes into view. Sign-up for continuing coverage on shares of $LHSIF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $LHSIF, either long or short, and we have not been compensated for this article.